Consensus ChampionX Corporation

Equities

CHX

US15872M1045

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
35.1 ^USD	-0.40%		-4.20%	+20.16%

Apr. 19	Schlumberger Posts Largely In-Line First-Quarter Results	MT
Apr. 19	Oilfield firm SLB's profit rises on international drilling demand	RE

Evolution of the average Target Price on ChampionX Corporation

Price target over the last 5 years

History of analyst recommendation changes

27ff57bbba636828645c1d.NRQleSDxvbVcDU6b3oScbWpZKgOIKWACtxSowaN5SMg.fGdJIE2iid4VZR3L883PXQ8VTG7KHgJLh3WRqMcpGp1ZTHAUa5v0_yk_PQ~295511963f8684e04bf7a43bcb65a479

Analyst Recommendations on ChampionX Corporation

Piper Sandler Raises ChampionX's Price Target to $40 From $32, Maintains Neutral Rating	Apr. 08	MT
Barclays Raises Price Target on ChampionX to $51 From $39, Maintains Overweight Rating	Apr. 04	MT
RBC Raises Price Target on Schlumberger to $69 From $66 Amid ChampionX Deal, Keeps Outperform Rating	Apr. 03	MT
ChampionX Insider Sold Shares Worth $978,408, According to a Recent SEC Filing	Apr. 01	MT
Piper Sandler Downgrades ChampionX to Neutral From Overweight, Adjusts Price Target to $32 From $38	Jan. 08	MT
Goldman Sachs Cuts Price Target on ChampionX to $32 From $37, Maintains Neutral Rating	Nov. 14	MT
Piper Sandler Adjusts Price Target on ChampionX to $38 From $42, Maintains Overweight Rating	23-10-27	MT
Barclays Upgrades ChampionX to Overweight Equal-Weight, Raises Price Target to $44 From $33	23-10-17	MT
Capital One Initiates ChampionX With Overweight Rating, $40 Price Target	23-07-14	MT
Citigroup Trims Price Target on ChampionX to $40 From $41, Maintains Buy Rating	23-04-05	MT
Goldman Sachs Adjusts ChampionX's Price Target to $32 From $21, Keeps Neutral Rating	22-11-02	MT
Citigroup Adjusts ChampionX Price Target to $34 From $30, Maintains Buy Rating	22-11-01	MT
Barclays Downgrades ChampionX to Equalweight From Overweight, Reduces Price Target to $28 From $38	22-10-06	MT
ANALYST RECOMMENDATIONS : Nvidia, Thermo Fisher Scientific, Danaher, Agilent Technologies, GDS Holdings...	22-08-25
Benchmark Starts ChampionX at Buy With $32 Price Target	22-08-25	MT
BofA Securities Upgrades ChampionX to Buy From Neutral; Price Target is $22	22-07-15	MT
Goldman Sachs Lowers Price Target for ChampionX to $21 From $26, Maintains Neutral Rating	22-07-12	MT
S&P Revises ChampionX Corp. Outlook To Positive On Improving Financial Measures, Ratings Affirmed	22-05-25	MT
Barclays Adjusts ChampionX's Price Target to $38 from $33, Keeps Overweight Rating	22-05-02	MT
Piper Sandler Lifts ChampionX to Overweight From Neutral, Price Target to $30 From $28	22-04-11	MT
BofA Securities Downgrades ChampionX to Neutral from Buy	22-03-11	MT
Goldman Sachs Upgrades ChampionX to Neutral From Sell; Price Target is $24	22-02-22	MT
Barclays Adjusts Price Target on ChampionX to $35 From $29, Reiterates Overweight Rating	21-11-01	MT
CHAMPIONX : Goldman Sachs Starts ChampionX at Sell With $22 Price Target	21-09-17	MT
ANALYST RECOMMENDATIONS : Anthem, GlaxoSmithKline, Flutter, IMI, Workspace...	21-07-05